Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Kailera Therapeutics is seeking an Associate Director, Program Management to drive cross-functional drug development programs at the Waltham, MA hub. You will oversee plans from initiation to completion, ensuring on-time delivery within scope and budget, while identifying risks and implementing solutions.
The role supports mid-stage assets KAI-4729 and Safiglipron (Phase 1–2). Onsite 3–4 days/week with a collaborative, fast-paced environment.
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
The Associate Director, Program Management will collaborate with cross-functional teams, including clinical, regulatory, non-clinical, and technical operations, to drive the overall program and several ad-hoc projects forward. This individual will oversee the development and execution of project plans from initiation to completion, ensuring the plan is completed on time, in scope, and within budget. Additionally, they will work closely with teams to proactively identify potential risks and implement effective solutions. A successful candidate must have experience managing drug development projects in a fast-paced environment, with a strong willingness to build relationships with cross-functional teams, dive into details, and address gaps as needed to ensure program success.
The Associate Director, Program Management, will support Kailera’s mid-stage assets, which are in Phase 1 and Phase 2 development. These include KAI-4729 (tri-agonist injectable) and Safiglipron (oral GLP-1).
Required location: Waltham, MA (hub-based, onsite 3-4 days per week)
$159,000—$195,000 USD
This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.
Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.
Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.